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Abstract: While mechanosynthesis of the target compound, 1-[2-(1H-indol-3-yl)-ethyl]-pyrrole-2,5-
dione, C14 H12 N2 O2, did not yield the desired product, it instead resulted in an open intermediate.
On the other hand, synthesis starting from the activated maleic anhydride yielded the final
maleimide compound. The outcome of the mechanosynthesis has been evaluated by powder X-ray
diffraction, and structures of both the final product and open intermediate have been confirmed
using single-crystal crystallography.
Keywords: mechanosynthesis; grinding; single-crystal structure; powder X-ray diffraction; maleic
anhydride; tryptamine
1. Introduction
This work forms a part of our study on epigenetic modulation by DNA methyltransferases
(Mtases) [1,2]. It was a consequence of attempting to synthesize analogues of N-phthalyl-L-tryptophan
(RG108), which are non-nucleosidic inhibitors of Mtases [3,4].
1-[2-(1H-Indol-3-yl)-ethyl]-pyrrole-2,5-dione, C14H12N2O2 (Scheme 1, compound 1) is a potential
Mtase inhibitor [4]. We report here our attempt to synthesize this compound by mechanosynthesis
based on a successful approach adopted for phthalimides using grinding of corresponding anhydrides
and amines [5].
This approach led to the corresponding open product, 1o.
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refcode OZITAT [7]) or as a salt with dicyclohexylamine (CSD refcode WADRAW [8]). The crystal 
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Scheme 1. Chemical diagram of compounds under study.
The crystal structure of N-phthalyl-L-tryptophan (RG108) has been obtained alone (CSD [6]
refcode OZITAT [7]) or as a salt with dicyclohexylamine (CSD refcode WADRAW [8]). The crystal
structure of a nitro-substituted analog of RG108 has also been determined (CSD refcode EVIWEM [9]).
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To the best of our knowledge, these are the only deposited crystal structures for this, otherwise well
documented, family of compounds.
2. Results and Discussion
2.1. Synthesis and Crystallization
2.1.1. Mechanosynthesis
Initial attempts to obtain target maleimide 1 were based on our previous work where
mechanosynthesis was used to prepare phthalimide compounds [5]. In brief, the starting solid
reactants, tryptamine (2) and maleic anhydride (3) (Figure 1), were ground in an equimolar ratio,
either manually using a mortar and pestle or mechanically using a vibration ball mill Retsch MM400
(Retsch GmbH, Haan, Germany ) (60 min at 30 Hz, 2–10 balls added to a 2 mL plastic vial). Progress of
reaction was monitored by powder X-ray diffraction (Panalytical ProX’pres, Almelo, the Netherlands,
Cu radiation) (Figure 2).
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Figure 2. Powder X-ray diffractograms showing the outcome of the grinding experiment. Starting solids
(maleic anhydrate and trypta ine), solid obtained after grinding (60 min at 30 Hz), solid obtained fter
heating (30 min at 140 ◦C). Diffractograms simulated on the basis of the single crystal structures of 1
and 1o are presented for comparison.
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Upon grinding, characteristic diffraction peaks of the reactants were replaced by peaks associated
to the new ground product (Figure 2). Recrystallization of the ground solid from a saturated solution
in a MeOH/toluene mixture led to small single crystals useful for crystal structure determination.
X-ray diffraction analysis revealed that the compound obtained upon grinding is the open maleamide
intermediate 1o (Section 2.2). This result is consistent with similar observations that we made
for phthalimides [5]. Powder diffractogram simulated on the basis of the single crystal structure
coordinates (Figure 2) corresponds to the experimental data recorded on the solid obtained after
grinding, confirming that the bulk powder corresponds to 1o. Conversion in almost quantitative
(>95%) as judged from NMR and powder X-ray diffraction data.
We expected to get the final, closed maleimide 1 on heating the intermediate [5]. Despite several
attempts, we were unable to convert intermediate 1o into the target compound 1.
A reasonable explanation for the failure of the formation of the desired product using unactivated
reactants is probably linked to the reduced nucleophilicity of the conjugated amide intermediate 1o.
Indeed, thermal and uncatalyzed amide formation has been scarcely reported [10,11] especially when
the nucleophile is conjugated amide.
2.1.2. Synthesis Using Activated Maleic Acid
As we were unsuccessful in mechanosynthesis of 1, we developed a procedure (Figure 3) based
on a similar approach described in the literature [12].
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Figure 3. Synthetic route to 1 using a solvent-based approach via activated maleic acid reactant.
DME: dimethylether; DCC: dicyclohexylcarbodiimide; OSu: N-oxysuccinimidyl group.
In brief, a solution of mono ethylmaleate (4) (5.204 g, 40 mmol) and N-hydroxysuccinimide (5)
(4.61 g, 40 mmol) in DME (15 mL) oled to 0 ◦C. Dicyclohexylcarbodiimide (DCC, 8.25 g, 40 mmol)
was dded and stirring was continued at his temperatur for 4 . The reaction mixture was allowed to
stand for 2 h in a refrigerator and then filtered. The solution was concentrated u de reduced pressure.
The residue was triturated in Et2O/hexane, filtered, and then dried in vacuo to afford solid methyl
succinimidylmaleate (6). Tryptamine (2) (0.32 g, 2.0 mmol) and sodium carbonate (1.06 g, 10 mmol)
were dissolved in water (15 mL), and then in acetonitrile (25 mL). Methyl succinimidylmaleate (6)
(0.45 g, 2 mmol) was added, and the mixture was stirred for 4 h. The solution was acidified to pH
1 with 2N HCl, diluted with EtOAc (100 mL), and washed with 1N HCl (2 × 100 mL) and water
(2× 100 mL). The organic phase was dried with MgSO4, filtered, and concentrated in vacuo to give final
maleimide 1 (Figure 3). Final product was recrystallized from a concentrated solution in acetonitrile
at room temperature. The yield of this reaction has not been optimized but as already very good
(>80%), consistent with data from the literature [12]. Single crystals suitable for crystallography were
obtained and led to the structure described in the following section.
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2.2. Structural Commentary
The open intermediate 1o (Figure 4a, Table 1) was obtained by grinding maleic anhydride
and tryptamine (Figure 1). The structure of the final target molecule 1 (Figure 4b, Table 1) was
obtained using activated methyl succinimidylmaleate (Figure 3) as confirmed by determination of its
crystal structure.
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Table 1. Experimental details of the crystal structure determination.
(1) (1o)
Chemical formula C14H12N2O2 C14H14N2O3
Mr 240.26 258.27
Crystal system, space group Orthorhombic, P212121 Monoclinic, P21/n
a, b, c (Å)
6.2720 (3), 8.9037 (6),
12.8304 (6), 12.0034 (10),
15.0252 (6) 12.1047 (8)
α, β, γ (◦) 90, 90, 90 90, 92.357 (6), 90
V (Å3) 1209.11 (9) 1292.59 (16)
Z 4 4
Radiation type Mo Kα Cu Kα
µ (mm−1) 0.09 0.78
Crystal size (mm) 1.0 × 0.8 × 0.5 0.13 × 0.07 × 0.05
Tmin, Tmax 0.917, 0.956 0.930, 0.960
No. of ref. measured, independent, and observed 4460, 2144, 1789 5570, 2181, 1524
Rint 0.036 0.069
θmax (◦) 25.0 64.0
R[F2 > 2σ(F2)], wR(F2), S 0.041, 0.097, 1.05 0.060, 0.185, 1.02
No. of reflections 2144 2011
No. of parameters 163 172
∆ρmax, ∆ρmin (e Å−3) 0.11, −0.16 0.23, −23
As expected, nitrogen atom N1 of the maleimide ring in 1 is sp2 hybridized (sum of valence angles
close to 360◦, C1–N1–C5 = 125.9(2)◦, C4–N1–C5 = 124.4(2)◦, C1–N1–C4 = 109.7(2)◦), and C–C and
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C–N bond lengths (Table 2) are intermediate between single and double bonds, suggesting electronic
delocalization within this ring.
In the open intermediate 1o, nitrogen atom N1 binds to C1=O and forms an amide. This group
is conjugated to the C2=C3–C4OOH part, as deduced from the bond lengths (Table 2). Within the
maleamide moiety, a strong O3–H3O···O1 intra-molecular hydrogen bond is observed (Table 3).
Table 2. Selected geometric features. Bond lengths (Å), valence angles (◦), and torsion angles (◦).
Compound 1
N1–C4 1.377 (3) C1–C2 1.482 (4)
N1–C1 1.380 (4) C2–C3 1.307 (4)
O1–C1 1.205 (3) C3–C4 1.480 (4)
O2–C4 1.208 (3)
C1–N1–C5–C6 −88.3 (3) C5–C6–C7–C8 15.9 (4)
N1–C5–C6–C7 −177.1 (2)
Compound 1o
N1–C1 1.323 (3) C1–C2 1.471 (4)
O2–C4 1.220 (3) C2–C3 1.330 (4)
O3–C4 1.290 (4) C3–C4 1.479 (4)
C1–N1–C5–C6 88.6 (3) C5–C6–C7–C8 93.4 (3)
N1–C5–C6–C7 −178.3 (2)
Table 3. Hydrogen bond geometry (Å, ◦).
D–H···A D–H H···A D···A D–H···A
Compound 1
N2–H2···O2 i 0.86 2.30 2.952 (3) 133
Compound 1o
O3–H3O···O1 0.82 1.68 2.490 (3) 171
N2–H2···O1 ii 0.86 2.09 2.938 (3) 169
N1–H1···O2 iii 0.86 2.18 2.941 (3) 147
Symmetry code: (i) –x − 12 , −y + 1, z − 12 ; (ii) –x + 1, −y + 1, −z; (iii) − 12 + x, 12 − y, 12 + z.
Conformation of the two compounds is distinct. In molecule 1, the planar indole ring is almost
perpendicular to the maleimide ring (acute angle between planes = 68.6(2)◦). In the open intermediate
1o, the planar indole heterocycle is almost parallel to the maleamide moiety (acute angle between
planes = 6.9(2)◦). This is also reflected in the values of the torsions angles defining the conformation of
the molecules (Table 2).
In both compounds, nitrogen N2 of the indole ring serves as a H-bond donor (Table 3).
For compound 1o, the position of H atom on oxygen atom O3 of the carboxylic acid was unambiguously
determined from the residual electron density. This H atom is involved in a strong intramolecular H
bond involving O3–H and the carbonyl oxygen atom (O1) of the amide moiety (Table 3).
In the crystal packing of 1 (Figure 5a), in addition to the H-bonds involving N2 and O2 (Table 3),
T-shaped pi–pi contacts are observed between the delocalized indole ring and the maleimide ring
(distance between centroids Cg(1)···Cg(2): 4.421(2)Å, and dihedral angle between planes: 41.5◦,
Cg(1) being the centroid of the five-membered ring N1–C1–C2–C3–C4 and Cg(2) the centroid of the
six-membered ring C9–C10–C11–C12–C13–C14). This leads to C–H···pi interaction (C3–H3···Cg(2)i:
3.631(3)Å with i = 12 − x, 1 − y, 12 + z). In the crystal packing of 1o (Figure 5b), in addition to the
intermolecular H–bonds that involve N1, N2, O1, and O2 (Table 3), parallel pi–pi stacking is observed
between the indole ring and the maleamide pseudo-cyclic.
Crystals 2016, 6, 153 6 of 8
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In conclusion, 1-[2-(1H-Indol-3-yl)-ethyl]-pyrrole-2,5-dione (1), a potential DNA methyltransferase
inhibitor, has been successfully synthesized using activated reactants and synthesis in solution.
Direct mechanosynthesis, starting from the unactivated reactant and using dry grinding, led to
the amide intermediate 1o. This molecule did not convert into the cyclized final product in contrast
with results obtained for phthalimides using dry grinding of corresponding unactivated anhydrides
and amines. Reduced nucleophilicity of the conjugated amide intermediate is probably part of the
explanation. Restricted conformation of molecule 1o, in the solid, and crystal packing further play
a role in the stability of the intermediate product.
As a perspective to this work, liquid-assisted grinding could be tested by addition of a few
drops of solvent during grinding. Mechanosynthesis starting from activated reactants is another
possible alternative.
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3. Materials and Methods
3.1. NMR Data
1o: 1H NMR (400 MHz DMSO) 10.82 (br s, 1H), 9.20 (br s, 1H), 7.50 (d, 1H, J = 7.79 Hz), 7.31 (d, 1H,
J = 8.01 Hz), 7.14 (s, 1H), 7.03 (t, 1H, J = 7.44 Hz), 6.95 (t, 1H, J = 7.44 Hz), 6.38 (dd, 1H, J1 = 12.59 Hz,
J2 = 1.14 Hz), 6.22 (dd, 1H, J1 = 12.59 Hz, J2 = 1.37 Hz), 3.44 (dd, 2H, J1 = 6.64 Hz, J2 = 6.64 Hz), 2.87 (t,
2H, J = 7.33 Hz);
13C NMR (400 MHz, CDCl3) 167.89, 166.04, 136.78, 134.16, 132.13, 127.59, 123.34, 121.49, 118.84,
118.64, 111.95, 111.72, 40.06, 24.96;
1: 1H NMR (400 MHz CDCl3) 8.03 (br s, 1H), 7.66 (d, 1H, J = 7.79 Hz), 7.34 (d, 1H, J = 8.01 Hz),
7.19 (t, 1H, J = 6.98 Hz), 7.13 (t, 1H, J = 6.98 Hz), 7.03 (s, 1H), 6.64 (s, 2H), 3.84 (t, 2H, J = 7.67 Hz), 3.06 (t,
2H, 7.67 Hz);
13C NMR (400 MHz, CDCl3) 170.94, 136.34, 134.13, 127.38, 122.28, 121.96, 119.36, 118.69, 111.91,
111.28, 38.55, 24.40.
3.2. Crystal Data Collection and Refinement
Crystal data, data collection, and structure refinement details are summarized in Table 1.
Crystal data used for the refinement were collected on a Gemini R Ultra diffractometer at room
temperature. Data were treated (cell determination and data reduction) using CrysAlis PRO (Rigaku
Oxford Diffraction, Oxford, UK). Structures were solved using SIR2004 [13] and refined with
SHELXL2014/8 [14].
For compound 1o, data had to be collected using an enhanced Cu radiation source, as only small
crystals could be obtained. In both structures, non-hydrogen atoms have been refined anisotropically.
Positions of H atoms were observed in the Fourier difference maps, then calculated at their ideal
position and refined using a riding model (C–H and N–H bond distances fixed to 0.93 and 0.86 Å,
respectively, thermal factors fixed to 1.2 times the value of the parent (C or N) atom). In structure 1o,
H atom on O3, forming a strong intra-molecular H bond, was found in the ∆F map and its position
was refined using a riding model: the thermal factor was fixed (1.5 times) on the basis of the value of
the oxygen atom (O3) to which it was covalently bound.
Final coordinates and structure factors have been deposited to CSD (CCDC 1508084-1508085).
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